Home » 제품 » Ready-to-Use NGS Panel » Clinical Exome
G-Mendeliome Clinical Exome Sequencing Panel
Sensitive Detection of Variants with Clinically Significant Genetic Diseases
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >Revolutionary Bioinformatics solution providing fast and
accurate, client-specific analysis services.
Trust CAS with your BI analysis !
Celemics offers easy-to-use kit with all components needed from RNA fragmentation to double-stranded cDNA synthesis suitable for NGS.
View Detail >Celemics exclusive enzymes and buffers for enhanced hybridization to ensure improved coverage and uniformity.
View Detail >Proven market-leading purification and size selection efficiency supported by Celemics’ unique magnetic bead-based chemistry. Compatible with all Celemics’ panels as well as other NGS providers
View Detail >High-quality streptavidin bead that selectively isolates biotinylated ligands bound to hybridization probes; minimizing DNA loss during the target enrichment process.
View Detail >CeleNM™ Bead streamlines library quantification and normalization in Next-Generation Sequencing (NGS). Say goodbye to traditional QC processes, saving time and costs while ensuring robust results. Experience uniform sequencing data distribution and comparable on-target ratios with CeleNM™ Bead.
View Detail >Celemics’ highly optimized polymerase ensures market-leading amplification efficiency and accuracy with minimized PCR bias and error rate.
View Detail >Highly optimized library preparation kit to be used with all Celemics ready-to-use or customized panels. Experience the incomparable efficiency and performance for NGS library preparation
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Celemics’ comprehensive NGS panel for somatic cancer allows highly accurate and comprehensive analysis for identifying significant mutations and variants for solid tumors.
Celemics’ comprehensive NGS panel for somatic cancer allows highly accurate and comprehensive analysis for identifying significant mutations and variants for solid tumors.
Celemics has developed NGS ctDNA-based kits for colon, breast, and lung cancer assays. We have integrated our market-leading proprietary technologies and thoroughly validated and optimized as ready-to-use panels for clinical diagnostics.
Celemics offers end-to-end NGS-based detection and discovery solutions for Biopharma, CRO, and Drug discovery research fields.
In order to overcome the limitations of analyzing clinical diseases with conventional whole exome sequencing, Celemics introduces NGS-based clinical diagnostic solution for efficient detection of disease-causing variants for inherited diseases.
Celemics offers flexible choice of assessing extensive target regions associated with Pharmacogenomics for client-specific drug prescription and drug metabolism.
Celemics’ virus panels are designed to detect and identify disease-causing viruses. With our exclusive technologies, we provide efficient and accurate detection of targeted virus trains as well as procurement of credible data for whole viral genome sequencing.
To fulfill the expectations and growing needs for sequencing animals and plants, Celemics offers range of ready-to-use applicable to agrigenomics field as well as an option for developing customized NGS panel to specifically fit individual research purposes.
With Celemics’ proprietary technologies for assay development and optimization, we offer complete and robust NGS solutions for transcriptome, fusion, and isoform analyses for various sample types and conditions.
Celemics provides comprehensive solution for DNA methylation sequencing with proprietary probes specifically designed for methyl-seq, enabling accurate detection of methylation sites.
Complete solution with flexible panel design for characterization and differentiation of a myriad of microbial species.
Accurate and efficient analysis of IGH population that can detect MRD as low as 10-6 with optimized primers that can minimize sequencing loss and PCR duplications.
Celemics introduces revolutionary BI solution aiming to provide client-specific service. We provide fast, accurate, and sophisticated analyses of your NGS data accompanied by our proprietary bioinformatics pipeline.
The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >Utilizing NGS-based target enrichment methods for higher genotyping efficiency and accuracy. Providing cost-effective and optimized experiment compared to conventional methods, such as GBS, PCR and microarray in plant and animal research
View Detail >
Revolutionary Bioinformatics solution providing fast and
accurate, client-specific analysis services.
Trust CAS with your BI analysis
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >In-silico designed and wet-lab validated exclusive probes to ensure state-of-the-art capture performance
View Detail >Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >Let’s change the NGS market together – our global presence and partners world-wide
View Detail >Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >Sensitive Detection of Variants with Clinically Significant Genetic Diseases
Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) 패널은 기존의 Whole Exome 시퀀싱의 단점을 커버하기 위해 디자인된 패널입니다. CES는 타겟 영역을 질병과 연관 있는 유전자들로 구성하여 빠르고 효율적으로 진단 검사에 사용하는 것에 초점을 두고 개발된 패널로 Whole Exome 시퀀싱 패널에 비해 컴팩트한 타겟 영역을 가지고 있어 관심 유전자를 비용 효율적으로 검사할 수 있습니다. 특히 G-Mendeliome CES 패널은 의학적으로 중요하다고 여겨져 시중의 다른 패널들에서도 널리 검사하는 유전자 뿐 아니라 추가적으로 유용한 정보를 포함하고 있는 유전자들도 모두 포함하고 있어 매우 포괄적인 정보를 얻을 수 있습니다.
CES 패널은 7,000개 이상의 유전자라는 넓은 범위의 타겟 영역을 가지고 있습니다. 의학적으로 중요한 유전자들로 구성되어 있으며 특히 여타 시장의 다른 패널에서는 다루지 않는 유전자들도 다수 포함하고 있어 활용도 높은 패널입니다.
Company A + Company B + over 70 genes
The CES Panel was developed to meet the needs of GC Genome,the largest clinical NGS service provider in South Korea,to solve the problems of poor diagnostic rates and high costs.
Company A
SORT1
GSTM1
SLC16A1
IL10
.
.
TNFRSF4
CASP9
MIR30C1
IL19
COL6A5
.
.
SCNN1D
PRDM16
TNFRSF9
LCK
ZNF419
.
.
Company B
CDK11B
AZIN2
INSRR
TTC7A
CAMK1
.
.
over
70 genes
Whole Exome보다 작은 타겟 영역을 가지고 있으나 의학적으로 중요한 유전자들을 두루 포함하도록 구성된 패널로 보다 낮은 비용으로 효율적인 시퀀싱을 할 수 있습니다. On-target Ratio, Uniformity 등 최고의 성능을 낼 수 있도록 디자인된 패널을 공급해 드립니다.
Gene Add-on 서비스로 타겟 영역을 추가하거나 완전한 맞춤형 패널을 만드실 수 있습니다.
CES Expanded 패널 이용자분들을 대상으로 추가 Clinical 리포트를 제공해 드립니다.
Illumina, Thermo Fisher, MGI 장비에 최적화된 시약 및 프로토콜을 제공해 드립니다.
Gene count* | 5,516 / 7,563 genes |
---|---|
Covered region | CDS, hotspots, Mitochondrial genome |
Target size | 13.8 / 19.6 Mb |
Mutation type | SNV, Indel, CNV |
Sample type(amount) | Blood (> 50 ng of fragmented DNA) |
Platform | All sequencers from Illumina, Thermo Fisher, MGI, PacBio, and Oxford Nanopore |
Bioinformatics Support |
① Primary Analysis: FASTQ to annotated VCF ② Secondary Analysis: CNV, Large InDel ③ Tertiary Analysis: Clinical interpretation |
G-Mendeliome CES panel contains around 7,000 disease-related genes as target regions. The related diseases are listed in the table below
Category | Related Diseases |
---|---|
Cardiology | Aortopathy and connective tissue disorders |
Arrhythmia | |
Cardiomyopathy | |
Congenital heart defect | |
Dyslipidemia | |
Other cardiovascular diseases | |
Pulmonary hypertension | |
Dermatology | Adams-Oliver syndrome |
Albinism | |
Cardiofaciocutaneous syndrome | |
Cutis laxa | |
Dyskeratosis congenita | |
Ectodermal dysplasia | |
Ehlers-Danlos syndrome | |
Epidermolysis bullosa | |
Hereditary acrodermatitis enteropathica | |
Hermansky-Pudlak syndrome | |
Hypotrichosis | |
Ichthyosis | |
Neurofibromatosis | |
Pachyonychia congenita | |
Palmoplantar keratoderma | |
Progeria and Progeroid Syndromes | |
Skin cancer | |
Tuberous sclerosis | |
Waardenburg syndrome | |
Xeroderma pigmentosum | |
Endocrinology | Adrenal hyperplasia |
Diabetes | |
Hyperinsulinism | |
Hyperparathyroidism | |
Hypothyroidism | |
Kallmann syndrome | |
Multiple endocrine neoplasia | |
Obesity | |
Pancreatitis | |
Premature ovarian failure | |
ENT | Hearing loss |
GI/Hepatology | Cholestasis |
Congenital diarrhea | |
Congenital hepatic fibrosis | |
Gastrointestinal atresia | |
Hirschsprung disease | |
Polycystic liver disease | |
Hematology | Anemia |
Bleeding&Thrombotic disorder | |
Bone marrow failure | |
Congenital neutropenia | |
Hemochromatosis | |
RBC membrane disorder | |
Immunology | Antibody deficiencies |
Autoinflammatory disorders | |
Combined T/B cell deficiencies | |
Complement deficiencies | |
Defects in intrinsic and innate immunity | |
Immune dysregulation | |
Phagocytic defects |
Metabolism | Aminoacidopathies |
---|---|
Carbohydrate disorders | |
Congenital disorders of glycosylation | |
Creatine biosynthesis disorders | |
Fatty acid oxidation defects | |
Lipodystrophy | |
Lysosomal storage disorders | |
Organic acidemias | |
Peroxisomal disorders | |
Porphyria | |
Purine/Pyrimidine metabolism disorders | |
Pyruvate metabolism and tricarboxylic acid cycle defects | |
Urea cycle disorders | |
Nephrology | Bartter syndrome |
Ciliopathies | |
Diabetes insipidus | |
Hemolytic uremic syndrome | |
Hypokalemia | |
Hypomagnesemia | |
Hypophosphatemic rickets | |
Nephrolithiasis | |
Nephrotic syndrome/Focal glomerulonephrosis | |
Pseudohypoaldosteronism | |
Renal malformation | |
Renal tubular acidosis | |
Neurology | Autism |
Movement disorders | |
Neurodegenerative disorders | |
Neuromuscular disorders | |
Neuropathies and related disorders | |
Seizures and Brain abnormalities | |
Oncology | Breast and gynecological cancer |
Colorectal cancer | |
Endocrine cancer | |
Gastrointestinal cancer | |
Hematologic malignancy | |
Lung cancer | |
Nervous system/brain cancer | |
Pancreatic cancer | |
Prostate cancer | |
Renal cancer | |
Sarcoma | |
Skin cancer | |
Ophthalmology | Albinism |
Cataract/Ectopia lentis | |
Corneal dystrophy | |
Glaucoma | |
Microphthalmia/Anophthalmia | |
Nystagmus | |
Ophthalmoplegia/Oculomotor apraxia | |
Optic atrophy | |
Retinal dystrophy | |
Retinoblastoma | |
Pulmonology | Bronchiectasis |
Central hypoventilation/Apnea | |
Cystic fibrosis | |
Cystic lung disease | |
Hermansky-Pudlak syndrome | |
Interstitial lung disease | |
Primary ciliary dyskinesia | |
Surfactant dysfunction | |
Skeletal disorders | Amelogenesis imperfecta |
Arthrogryposes | |
Cleft lip palate | |
Craniosynostosis | |
Exostosis | |
Facial dysostosis | |
Macrocephaly/Overgrowth syndrome | |
Osteopetrosis | |
Short stature syndrome | |
Skeletal dysplasia |
Gene count* | 5,508 / 7,513 genes |
---|---|
Covered region | CDS, hotspots, Mitochondrial genome |
Target size | 13.8 / 19.6 Mb |
Mutation type | SNV, Indel, CNV |
Sample type(amount) | Blood (> 50 ng of fragmented DNA) |
Platform | All sequencers from Illumina, Thermo Fisher, MGI, PacBio, and Oxford Nanopore |
Bioinformatics Support |
① Primary Analysis: FASTQ to annotated VCF ② Secondary Analysis: CNV, Large InDel ③ Tertiary Analysis: Clinical interpretation |
G-Mendeliome CES panel contains around 7,000 disease-related genes as target regions. The related diseases are listed in the table below
Category | Related Diseases |
---|---|
Cardiology | Aortopathy and connective tissue disorders |
Arrhythmia | |
Cardiomyopathy | |
Congenital heart defect | |
Dyslipidemia | |
Other cardiovascular diseases | |
Pulmonary hypertension | |
Dermatology | Adams-Oliver syndrome |
Albinism | |
Cardiofaciocutaneous syndrome | |
Cutis laxa | |
Dyskeratosis congenita | |
Ectodermal dysplasia | |
Ehlers-Danlos syndrome | |
Epidermolysis bullosa | |
Hereditary acrodermatitis enteropathica | |
Hermansky-Pudlak syndrome | |
Hypotrichosis | |
Ichthyosis | |
Neurofibromatosis | |
Pachyonychia congenita | |
Palmoplantar keratoderma | |
Progeria and Progeroid Syndromes | |
Skin cancer | |
Tuberous sclerosis | |
Waardenburg syndrome | |
Xeroderma pigmentosum | |
Endocrinology | Adrenal hyperplasia |
Diabetes | |
Hyperinsulinism | |
Hyperparathyroidism | |
Hypothyroidism | |
Kallmann syndrome | |
Multiple endocrine neoplasia | |
Obesity | |
Pancreatitis | |
Premature ovarian failure | |
ENT | Hearing loss |
GI/Hepatology | Cholestasis |
Congenital diarrhea | |
Congenital hepatic fibrosis | |
Gastrointestinal atresia | |
Hirschsprung disease | |
Polycystic liver disease | |
Hematology | Anemia |
Bleeding&Thrombotic disorder | |
Bone marrow failure | |
Congenital neutropenia | |
Hemochromatosis | |
RBC membrane disorder | |
Immunology | Antibody deficiencies |
Autoinflammatory disorders | |
Combined T/B cell deficiencies | |
Complement deficiencies | |
Defects in intrinsic and innate immunity | |
Immune dysregulation | |
Phagocytic defects |
Metabolism | Aminoacidopathies |
---|---|
Carbohydrate disorders | |
Congenital disorders of glycosylation | |
Creatine biosynthesis disorders | |
Fatty acid oxidation defects | |
Lipodystrophy | |
Lysosomal storage disorders | |
Organic acidemias | |
Peroxisomal disorders | |
Porphyria | |
Purine/Pyrimidine metabolism disorders | |
Pyruvate metabolism and tricarboxylic acid cycle defects | |
Urea cycle disorders | |
Nephrology | Bartter syndrome |
Ciliopathies | |
Diabetes insipidus | |
Hemolytic uremic syndrome | |
Hypokalemia | |
Hypomagnesemia | |
Hypophosphatemic rickets | |
Nephrolithiasis | |
Nephrotic syndrome/Focal glomerulonephrosis | |
Pseudohypoaldosteronism | |
Renal malformation | |
Renal tubular acidosis | |
Neurology | Autism |
Movement disorders | |
Neurodegenerative disorders | |
Neuromuscular disorders | |
Neuropathies and related disorders | |
Seizures and Brain abnormalities | |
Oncology | Breast and gynecological cancer |
Colorectal cancer | |
Endocrine cancer | |
Gastrointestinal cancer | |
Hematologic malignancy | |
Lung cancer | |
Nervous system/brain cancer | |
Pancreatic cancer | |
Prostate cancer | |
Renal cancer | |
Sarcoma | |
Skin cancer | |
Ophthalmology | Albinism |
Cataract/Ectopia lentis | |
Corneal dystrophy | |
Glaucoma | |
Microphthalmia/Anophthalmia | |
Nystagmus | |
Ophthalmoplegia/Oculomotor apraxia | |
Optic atrophy | |
Retinal dystrophy | |
Retinoblastoma | |
Pulmonology | Bronchiectasis |
Central hypoventilation/Apnea | |
Cystic fibrosis | |
Cystic lung disease | |
Hermansky-Pudlak syndrome | |
Interstitial lung disease | |
Primary ciliary dyskinesia | |
Surfactant dysfunction | |
Skeletal disorders | Amelogenesis imperfecta |
Arthrogryposes | |
Cleft lip palate | |
Craniosynostosis | |
Exostosis | |
Facial dysostosis | |
Macrocephaly/Overgrowth syndrome | |
Osteopetrosis | |
Short stature syndrome | |
Skeletal dysplasia |
Protein-coding 영역을 폭넓게 포함하고 있으며, 높은 패널 성능과 BI 분석 솔루션을 기반으로 비용 효율적인 Exome 분석 가능
Protein-coding 영역을 폭넓게 포함하고 있으며, 높은 패널 성능과 BI 분석 솔루션을 기반으로 비용 효율적인 Exome 분석 가능
NGS Library Preparation 키트로 셀레믹스의 Target Enrichment 패널에 최적화된 키트
셀레믹스에서 제공하는 BI 분석 서비스로 다양한 수준의 분석 결과 제공 가능
최고 품질의 마그네틱 비드로 사용하기 편리하며 높은 재현성을 보여 NGS 실험에 최적화된 비드
Technical Resources
[Product Sheet] Celemics Clinical Exome Sequencing Panel
Celemics Target Enrichment Panel Overview
Celemics Products & Services
Safety Data Sheets
최신 MSDS 파일이 필요하시면 ‘Contact Us‘를 통해 문의 주시기 바랍니다.
MSDS_G-Mendeliome Clinical Exome Panels_Illumina
MSDS_G-Mendeliome Clinical Exome Panels_Thermo Fisher
MSDS_G-Mendeliome Clinical Exome Panels_MGI